REPLIMUNE GROUP, INC. Depreciation
REPLIMUNE GROUP, INC. (REPL) reported Depreciation of $700.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-08-08
- REPLIMUNE GROUP, INC. depreciation for the quarter ending 2024-06-30 was $700.00K, a 16.67% increase year-over-year.
- REPLIMUNE GROUP, INC. depreciation for the quarter ending 2023-12-31 was $700.00K, a 0.00% change year-over-year.
- REPLIMUNE GROUP, INC. depreciation for the quarter ending 2023-09-30 was $700.00K, a 16.67% increase year-over-year.
- REPLIMUNE GROUP, INC. depreciation for the quarter ending 2023-06-30 was $600.00K, a 3.23% decline year-over-year.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed |
|---|---|---|---|---|---|---|
| 2024-06-30 | $700.00K 10-Q · filed 2024-08-08 | |||||
| 2023-12-31 | $700.00K 10-Q · filed 2024-02-08 | $1.40M derived: sum of 2 quarters · filed 2024-02-08 | $2.00M 10-Q · filed 2024-02-08 | |||
| 2023-09-30 | $700.00K 10-Q · filed 2023-11-07 | $1.30M 10-Q · filed 2023-11-07 | ||||
| 2023-06-30 | $600.00K 10-Q · filed 2024-08-08 | $621.00K 10-Q · filed 2023-08-03 | ||||
| 2022-12-31 | $700.00K 10-Q · filed 2024-02-08 | $682.00K 10-Q · filed 2023-02-09 | $1.30M derived: sum of 2 quarters · filed 2024-02-08 | $1.90M 10-Q · filed 2024-02-08 | $1.92M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $600.00K 10-Q · filed 2023-11-07 | $617.00K 10-Q · filed 2022-11-03 | $1.20M 10-Q · filed 2023-11-07 | $1.24M 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | $620.00K 10-Q · filed 2023-08-03 | |||||
| 2021-12-31 | $548.00K 10-Q · filed 2023-02-09 | $1.08M derived: sum of 2 quarters · filed 2023-02-09 | $1.60M 10-Q · filed 2023-02-09 | |||
| 2021-09-30 | $532.00K 10-Q · filed 2022-11-03 | $1.05M 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | $518.00K 10-Q · filed 2022-08-04 | |||||
| 2020-12-31 | $402.00K 10-Q · filed 2022-02-03 | $827.00K derived: sum of 2 quarters · filed 2022-02-03 | $1.22M 10-Q · filed 2022-02-03 | |||
| 2020-09-30 | $425.00K 10-Q · filed 2021-11-04 | $816.00K 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |